HOME » News & Media

    Vyome Therapeutics Announces Positive Results in Phase 2 Trial of VB-1953 for Moderate to Severe Acne

    16 Jun 2020

    Vyome Therapeutics, a clinical-stage company developing locally-acting, next generation therapeutics...

    View More
    Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operating Officer and Chief Financial Officer

    08 Jan 2020

    Vyome Therapeutics, a clinical-stage company developing locally-acting, next generation therapeutics...

    View More

    Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.